Summit Therapeutics Inc. Common Stock (SMMT) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for SMMT. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 209 institutions reported holding SMMT, with 65.5 million shares worth $1.1 billion in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Vanguard15,202,075$257MDECREASED
BlackRock10,363,750$175MINCREASED
FMR8,136,745$138MDECREASED
State Street6,093,474$103MDECREASED
Geode Capital Management3,489,224$59MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Bhaskar Anand (Chief Accounting Officer)AWARD100,0002026-10-08

Full institutional holdings, insider history, and congressional trades for Summit Therapeutics Inc. Common Stock on SentiSense.